Business Case Studies, Diversification Strategies Case Study, Merck KGaA's, Focused Diversification Strategy

print page
Tell A Friend

Case Categories

Diversification Strategies Case Study

Case Title:

Merck KGaA's 'Focused Diversification Strategy': The Prospects and Perils

Publication Year : 2006

Authors: Kalyani, Sumit Kumar Chaudhuri

Industry: Health Care

Region:USA Germany

Case Code: DIS0011

Teaching Note: Not Available

Structured Assignment: Not Available

Buy This Case Study

Traditionally, the global pharmaceutical industry has leveraged on its blockbuster model to become one of the most profitable industries in the world. However, since the 1990s, the industry has been witnessing a rapid growth in the generic drug business worldwide and to add to its woes even with increasing investments in R&D, drug innovations have declined. It is opined that the industry is heading towards a consolidation and this prompted Merck KGaA, a German pharmaceutical group, to bid for another German company, Schering AG. However, Schering refused the bid on the grounds that Merck had underestimated its value.

Pedagogical Objectives:

  • To understand the reasons and consequences of the changing business model of the global pharmaceutical industry
  • To discuss the probable synergies that Merck might accrue by acquiring Schering.

Keywords : Blockbuster model of global pharmaceutical industry; Growth of generic drugs; Consolidation in the global pharmaceutical industry; Decline in drug innovations; Increasing costs of drug innovations; Traditional drug manufacturers going generic; Constraints of new drug research; Diversification Strategies Case Study; Patent expires of blockbuster drugs; Rise of generic drug manufacturers

Recently Bought Case Studies

    Recently Bought Case Studies

    Executive Interviews

  • Kai Alexander SchlevogtKai Alexander Schlevogt

    Professor of international strategy and leadership at the National University of Singapore Business School. He serves as a Program Director of the Nestle Global Leadership Program, delivered in association with London Business School.
    Speaks on The China Factor
  • Al RiesAl Ries

    Chairman of Ries, an Atlanta-based marketing strategy firm
    Speaks on Brands and Branding
  • Derek W BunnDerek W Bunn

    Professor at London Business School.
    Speaks on Decision Making
  • View All Executive Interviews»

Contact us: IBS Case Development Centre (IBSCDC), IFHE Campus, Donthanapally, Sankarapally Road, Hyderabad-501 504, Andhra Pradesh, INDIA.
Mob: +91- 9640901313, Phone: +91 - 08417 - 236672, Fax : + 91 - 08417 - 236674

©2003-2010 IBS Case Development Centre. All rights reserved. | Careers | Privacy Policy | Terms of Use | Disclosure | Site Map xml sitemap